Donor-derived EBV-specific T cells

EBV-specific T cells · Ciusss de L'Est de l'Île de Montréal

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Donor-derived EBV-specific T cells, covering 2026-03-17 to 2026-03-23. Get the full timeline:

Most recent: Clinical Trial Update: Donor-Derived EBV-Specific T Cells for Life Threatening EBV-lymphoma (OLIP-EBV-TCL-01-HMR01) [NA]